Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-05-27 19:11:40 ET · period of report 2026-05-27 · accession 0001061983-26-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-27 19:11 | 2026-05-27 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +2,851 | 13.2K | +28% | $0 |
| D | 2026-05-27 19:11 | 2026-05-27 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +4,301 | 4,301 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | A | A | 2,851 | $0.00 | 13,216 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-05-27 | A | A | 4,301 | $0.00 | 4,301 | D | $77.15 · 2026-06-27 to 2036-05-26 | 4,301 Common Stock |